Prio Wealth Limited Partnership Gsk PLC Transaction History

Prio Wealth Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$30.0 - $37.92 $139,380 - $176,176	-4,646 Closed	0 $0
Q3 2022 Feb 27, 2023	SELL	$16.13 - $44.61 $76,149 - $210,603	-4,721 Closed	0 $0
Q2 2022 Feb 27, 2023	BUY	$42.05 - $47.77 $198,518 - $225,522	4,721 New	4,721 $209,000
Q1 2022 Feb 21, 2023	BUY	$40.23 - $47.74 $189,925 - $225,380	4,721 New	4,721 $206,000
Q4 2021 Feb 17, 2022	BUY	$38.88 - $45.31 $180,636 - $210,510	4,646 New	4,646 $205,000
Q4 2020 Feb 04, 2021	SELL	$34.07 - $39.94 $199,173 - $233,489	-5,846 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$37.87 - $43.58 $221,388 - $254,768	5,846 New	5,846 $238,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Prio Wealth Limited Partnership with notifications on news.